Mihai Lupu

Dr. Mihai Lupu

Carol Davila University of Medicine and Pharmacy Bucharest - Faculty of Medicine, Bucharest, Romania
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2017 in Oncology Reports
Verified
Journal Article
Open access
PDF file
Mihai LupuMihai Lupu
Mihai Lupu
ACAna Caruntu
Ana Caruntu
Constantin CaruntuConstantin Caruntu
Constantin Caruntu
LPLaura Maria Lucia Papagheorghe
Laura Maria Lucia Papagheorghe
MIMihaela Adriana Ilie
Mihaela Adriana Ilie
Aristidis TsatsakisAristidis Tsatsakis
Aristidis Tsatsakis
Non‑melanoma skin cancer (NMSC) is the most common form of cancer worldwide, comprising 95% of all cutaneous malignancies and approximately 40% of all cancers. In spite of intensive efforts aimed towards awareness campaigns and sun‑protective measures, epidemiological data indicate an increase in the incidence of NMSC. This category of skin cancers has many common environmental triggers. Arising primarily on sun‑exposed skin, it has been shown that ultraviolet radiation is, in the majority of cases, the main trigger involved in the pathogenesis of NMSC. Aside from the well‑known etiopathogenic factors, studies have indicated that several neuroactive factors are involved in the carcinogenesis of two of the most common types of NMSC, namely basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), with the exception of penile SCC, for which a paucity of specific data on their pathogenic role exists. The complex interaction between the peripheral nervous system and target cells in the skin appears to be mediated by locally released neuroendocrine factors, such as catecholamines, substance P, calcitonin gene‑related peptide and somatostatin, as well as neurohormones, such as proopiomelanocortin and its derived peptides, α‑melanocyte‑stimulating hormone and adrenocorticotropin. All these factors have been, at least at some point, a subject of debate regarding their precise role in the pathogenesis of NMSC. There is also a significant body of evidence indicating that psychological stress is a crucial impact factor influencing the course of skin cancers, including SCC and BCC. Numerous studies have suggested that neuroendocrine factor dysregulation, as observed in stress reactions, may be involved in tumorigenesis, accelerating the development and progression, and suppressing the regression of NMSC. Further studies are required in order to elucidate the exact mechanisms through which neuroactive molecules promote or inhibit cutaneous carcinogenesis, as this could lead to the development of more sophisticated and tailored treatment protocols, as well as open new perspectives in skin cancer research.

25 February 2019 in Oncology Letters
Verified
Journal Article
Open access
PDF file
MIMihaela Adriana Ilie
Mihaela Adriana Ilie
Mihai LupuMihai Lupu
Mihai Lupu
DLDaniela Lixandru
Daniela Lixandru
Mircea TampaMircea Tampa
Mircea Tampa
Simona Roxana GeorgescuSimona Roxana Georgescu
Simona Roxana Georgescu
DBDaniel Boda
Daniel Boda
Confocal laser scanning microscopy (CLSM) is a modern imaging technique that enables the in vivo or ex vivo characterization of skin lesions located in the epidermis and superficial dermis with a high quasi-microscopic resolution. Currently, it is considered to be the most promising imaging tool for the evaluation of superficial skin tumors. The in vivo mode adds the advantage of noninvasive, dynamic, in real-time assessment of the tumor associated vasculature and inflammation. It offers the possibility to repeatedly examine the same skin area without causing any damage and to monitor disease progression and treatment outcome. Furthermore, this novel technology allows the evaluation of the entire lesion and can be used to guide biopsies and to define tumor margins before surgical excision or other invasive therapies. CLSM diagnostic features may differentiate between the various histologic subtypes of skin tumors and therefore helps in choosing the best therapeutic approach. In this study, we present the CLSM characteristic features of the most common melanocytic and non-melanocytic skin tumors, as well as future possible CLSM applications in the study of experimental skin tumorigenesis on animal models.

23 August 2016 in Disease Markers
Verified
Journal Article
Open access
PDF file
VVVlad Mihai Voiculescu
Vlad Mihai Voiculescu
BCBogdan Calenic
Bogdan Calenic
MGMihaela Ghita
Mihaela Ghita
Mihai LupuMihai Lupu
Mihai Lupu
Ana CaruntuAna Caruntu
Ana Caruntu
Constantin CaruntuConstantin Caruntu
Constantin Caruntu
Squamous cells carcinoma (SCC) is the second most frequent of the keratinocyte-derived malignancies after basal cell carcinoma and is associated with a significant psychosocial and economic burden for both the patient himself and society. Reported risk factors for the malignant transformation of keratinocytes and development of SCC include ultraviolet light exposure, followed by chronic scarring and inflammation, exposure to chemical compounds (arsenic, insecticides, and pesticides), and immune-suppression. Despite various available treatment methods and recent advances in noninvasive or minimal invasive diagnostic techniques, the risk recurrence and metastasis are far from being negligible, even in patients with negative histological margins and lymph nodes. Analyzing normal, dysplastic, and malignant keratinocyte proteome holds special promise for novel biomarker discovery in SCC that could be used in the future for early detection, risk assessment, tumor monitoring, and development of targeted therapeutic strategies.

10 January 2019 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
VVVlad Mihai Voiculescu
Vlad Mihai Voiculescu
CLCristina Victoria Lisievici
Cristina Victoria Lisievici
Mihai LupuMihai Lupu
Mihai Lupu
CVCristina Vajaitu
Cristina Vajaitu
CDCarmen Cristina Draghici
Carmen Cristina Draghici
Constantin CaruntuConstantin Caruntu
Constantin Caruntu
Taking into consideration that the immune system plays a very important role in the development of melanoma and non-melanoma skin cancers, which have a high prevalence in immunosuppressed patients and after prolonged ultraviolet radiation, the interest in developing novel therapies, in particular targeting the inflammation in cancer, has increased in the past years. The latest data suggest that therapies such as imiquimod (IMQ), ingenol mebutate (IM), 5-fluorouracil (5-FU), retinoids, and nonsteroidal anti-inflammatory drugs (NSAIDs) have been used with success in the topical treatment of some cancers. Herein, we review the topical treatment targeting the inflammation in skin cancer and the mechanisms involved in these processes. Currently, various associations have shown a superior success rate than monotherapy, such as systemic acitretin and topical IMQ, topical 5-FU with tretinoin cream, or IMQ with checkpoint inhibitor cytotoxic T lymphocyte antigen 4. Novel therapies targeting Toll-like receptor-7 (TLR-7) with higher selectivity than IMQ are also of great interest.

7 February 2020
Verified
Book Chapter
Closed access
PDF file
Simona Roxana GeorgescuSimona Roxana Georgescu
Simona Roxana Georgescu
Mircea TampaMircea Tampa
Mircea Tampa
CMCristina Iulia Mitran
Cristina Iulia Mitran
MMMadalina Irina Mitran
Madalina Irina Mitran
Constantin CaruntuConstantin Caruntu
Constantin Caruntu
Monica NeaguMonica Neagu
Monica Neagu

8 May 2021 in Cancers
Verified
Journal Article
Open access
PDF file
Ana CaruntuAna Caruntu
Ana Caruntu
LMLiliana Moraru
Liliana Moraru
Mihai LupuMihai Lupu
Mihai Lupu
FVFlorina Vasilescu
Florina Vasilescu
MDMarius Dumitrescu
Marius Dumitrescu
Sabina ZuracSabina Zurac
Sabina Zurac
(1) Background: The immune microenvironment plays an important role in carcinogenesis and has prognostic potential in many types of cancer. In this study we assess the prognostic character of tumor-infiltrating immune cells CD4+, CD8+ and CD56+ in resectable oral squamous cell carcinoma (OSCC); (2) Methods: We have evaluated the densities of CD4+, CD8+ and CD56+ in two distinct compartments, intratumor and invasion front, in 90 patients with OSCC; (3) Results: Significant differences were found between the tumor compartments for the CD4+ and CD8+ lymphocytes. An improved outcome (OS) was seen in patients with high densities of intratumor CD8+ lymphocytes (p = 0.0086), CD8+ lymphocytes at the front of invasion (p = 0.0011) and for intratumor CD56+ cells (p = 0.0016). Multivariate analysis confirmed the independent prognostic role of CD8+ at the front of invasion (OR = 3.75, CI95% 1.17–12.35, p = 0.026) and for intratumor CD56+ cells (OR = 3.669, CI95% 1.09–15.37, p = 0.035); (4) Conclusions: Tumor-infiltrating CD8+ lymphocytes at the front of invasion and CD56+ in the intratumor compartment display predictive traits in OSCC. A reach immune infiltration with these types of cells is associated with an improved patient outcome.